new semaglutide drugs Novo Nordisk's weight-loss pill wins FDA approval Key lawmaker wants CT to

and Metabolism 92 (5), 17541757

Nikolaos Zacharias, a vascular surgeon at Harvard-affiliated Massachusetts General Hospital

The reality is more nuanced: while some people experiment with extended intervals, clinical evidence and real-world outcomes show that consistent, appropriately-timed dosing produces better metabolic outcomes

Understanding the medication's glucose-dependent mechanism and associated risk factors is essential for safe prescribing and patient counselling

Sun Pharma, like Dr Reddy's Lab, can't sell semaglutide-based products in India until March 2026 when Novo Nordisks patent expires December 10, 2025 / 13:50 IST semaglutide Viswanath Pilla is a business journalist with 16 years of reporting experience